Old Web
English
Sign In
Acemap
>
authorDetail
>
Chong-Wen Si
Chong-Wen Si
Peking University
Medicine
Internal medicine
Hepatitis B
Adverse effect
Tenofovir
5
Papers
73
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48
2019
Medicine
Rong-Yue Liang
Jing-hang Xu
Chong-Wen Si
Sa Wang
Jia Shang
Zujiang Yu
Qing Mao
Qing Xie
Wei Zhao
Jun Li
Zhiliang Gao
Shanming Wu
Hong Tang
Jun Cheng
Xinyue Chen
Wenhong Zhang
Hao Wang
Zhong-Nan Xu
Ling Wang
Jun Dai
Yanyan Yu
Show All
Source
Cite
Save
Citations (1)
Therapeutic efficacy of 18 α-Diammonium glycyrrhizinate phosphatidylcholine complex in patients with chronic virus hepatitis
2008
Hong Zhao
Chong-Wen Si
Show All
Source
Cite
Save
Citations (0)
1